Delivery Order SPE2DB20D7059-SPE2DB25FQPB4
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order from the Defense Logistics Agency (DLA) for Rifampin 300 mg capsules (60-count units) with a ceiling value of $1,763.68. The contract, awarded on September 2, 2025, with an ultimate completion date of September 3, 2025, operates under firm fixed-price terms with no set-aside designation and represents a competitive award. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,707.48 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules in unit dose packaging (100 count). The contract was competitively awarded without set-aside provisions under a firm fixed price arrangement, with an ultimate completion date of August 14, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 24, 2025, for the supply of Rifampin 300 mg capsules (60-count packages). The contract is valued at $81,201.10 with a firm fixed-price structure and a completion date of September 25, 2025. This non-set-aside delivery order was competitively awarded and represents a continuation of AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded a delivery order valued at $2,630.74 to AmerisourceBergen Drug Corp for 60-count bottles of Rifampin 300 mg capsules, with delivery to the company's headquarters in Conshohocken, Pennsylvania. The contract was awarded on August 6, 2025, under firm fixed price terms with an ultimate completion date of August 7, 2025, and utilized no set-aside designation, indicating competitive award. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $5,136.17 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Rifampin 300 mg capsules (60-count units). The delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by September 18, 2025, with performance based in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $17,169.04 delivery order to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (30-count) on July 17, 2025, with a completion date of July 18, 2025. This is a firm fixed-price contract with no set-aside designation, awarded through open competition. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,264.00 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Rifampin 300 mg capsules (60-count units). This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by September 2, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Rifampin is a first-line antibiotic commonly used in the treatment of tuberculosis and other...
- The Defense Logistics Agency awarded a $24.7K delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Rifampin 300 mg capsules (60-count units). This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by September 9, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Rifampin is a critical antibiotic used primarily for treating tuberculosis and certain other...
- The Defense Logistics Agency awarded a competitive delivery order valued at $1,200.66 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 15, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,386.21 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units). The contract was competitively awarded without set-aside provisions and carries a firm fixed price structure with an ultimate completion date of September 16, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the performing location for this order. This delivery order is issued under the company's...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FQPB4Delivery Order
AmerisourceBergen Drug Corp has been awarded a delivery order valued at $1,200.66 by the Defense Logistics Agency for the supply of Rifampin 300 mg capsules (60-count units). This is a firm fixed price, non-competitive contract awarded on August 26, 2025, with a completion date of August 27, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total ceiling value of $999,999,999.00 and extends through December 2026. Rifampin is an antibiotic commonly used in the treatment of tuberculosis and other mycobacterial infections within military and federal healthcare systems. AmerisourceBergen serves as a critical pharmaceutical distributor for the Defense Logistics Agency's medical supply chain, fulfilling a comprehensive range of medication and supply requirements across the Department of Defense healthcare network. The company's extensive federal contracting history demonstrates its capability to deliver both brand-name and generic pharmaceuticals, vaccines, and specialized medical supplies to support military readiness and healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/26/25 |